Bluejay Diagnostics (BJDX) Depreciation & Amortization (CF) (2020 - 2026)
Bluejay Diagnostics recorded quarterly Depreciation & Amortization (CF) of $27763.0 in Q1 2026, up 1.27% quarter-over-quarter from $27415.0 in Q4 2025, and up 50.88% year-over-year from $18401.0 in Q1 2025.
Bluejay Diagnostics' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $27763.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 50.88% year-over-year to $27763.0; the TTM figure through Mar 2026 stood at $83544.0 (up 12.43% YoY), while the FY2025 annual figure was $74182.0, down 1.9% from the prior year.
- Depreciation & Amortization (CF) came in at $27763.0 for Q1 2026 at Bluejay Diagnostics, up from $27415.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $253174.0 in Q3 2023 to a low of $10624.0 in Q3 2025.
- A 5-year average of $50392.8 and a median of $27415.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) soared 501.02% in 2023 and slumped 93.02% in 2024, its largest moves.
- Bluejay Diagnostics' Depreciation & Amortization (CF) stood at $30682.0 in 2022, then dropped by 27.18% to $22342.0 in 2023, then decreased by 11.49% to $19775.0 in 2024, then jumped by 38.63% to $27415.0 in 2025, then advanced by 1.27% to $27763.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $27763.0, $27415.0, and $10624.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | 27,763.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,763.00 |
| Mar 31, 2026 | 27,763.00 |
| Dec 31, 2025 | 27,415.00 |
| Dec 31, 2025 | 27,415.00 |
| Sep 30, 2025 | 10,624.00 |
| Sep 30, 2025 | 10,624.00 |
| Jun 30, 2025 | 17,742.00 |
| Jun 30, 2025 | 17,742.00 |
| Mar 31, 2025 | 18,401.00 |
| Mar 31, 2025 | 18,401.00 |
| Dec 31, 2024 | 19,775.00 |
| Dec 31, 2024 | 19,775.00 |
| Sep 30, 2024 | 17,665.00 |
| Sep 30, 2024 | 17,665.00 |
| Jun 30, 2024 | 18,464.00 |
| Jun 30, 2024 | 18,464.00 |
| Mar 31, 2024 | 19,714.00 |
| Mar 31, 2024 | 19,714.00 |
| Dec 31, 2023 | 22,342.00 |
| Dec 31, 2023 | 22,342.00 |
| Sep 30, 2023 | 253,174.00 |
| Sep 30, 2023 | 253,174.00 |
| Jun 30, 2023 | 202,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Mar 31, 2023 | 45,000.00 |
| Dec 31, 2022 | 30,682.00 |
| Dec 31, 2022 | 30,682.00 |
| Sep 30, 2022 | 42,124.00 |
| Sep 30, 2022 | 42,124.00 |
| Jun 30, 2022 | 43,821.00 |
| Jun 30, 2022 | 43,821.00 |
| Mar 31, 2022 | 39,971.00 |
| Mar 31, 2022 | 39,971.00 |
| Dec 31, 2021 | 39,212.00 |
| Dec 31, 2021 | 39,212.00 |
| Sep 30, 2021 | 38,135.00 |
| Sep 30, 2021 | 38,135.00 |
| Jun 30, 2021 | 27,541.00 |
| Jun 30, 2021 | 27,541.00 |
| Mar 31, 2021 | 40,831.00 |
| Mar 31, 2021 | 40,831.00 |
| Dec 31, 2020 | 45,897.00 |
| Dec 31, 2020 | 45,897.00 |